The Pharmaceutical Journal
Vol 276 No 7383 p35
14 January 2006

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Related websites
Avian flu resources

Vaccine application

GlaxoSmithKline Biologicals has submitted the first pandemic influenza vaccine application to the European Medicines Agency. The application has been conceived using the “core pandemic dossier” model, whereby a “mock-up” vaccine is approved in advance.